C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59

Scandinavian Journal of Immunology

Volumn 43, Issue 4, 1996, Pages 361-366

  Miyagawa, S ^a,d   Mikata, S ^a,d   Shirakura, R ^a   Matsuda, H ^b   Nagasawa, S ^c   Terado, A ^d   Hatanaka, M ^d   Matsumoto, M ^d   Seya, T ^d  

^a Biomedical Research Center   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d CENTER FOR ADULT DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C9; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; COMPLEMENT DEPENDENT CYTOTOXICITY; DNA TRANSFECTION; ENDOTHELIUM CELL; GRAFT REJECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SWINE; XENOGRAFT;

EID: 0029966536     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-50.x     Document Type: Article

References (26)

1. Sugita Y, Nakano Y, Tomita M. Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane. J Biochem 1988;104: 633-7.
2. Nakano Y, Tozaki T, Kikuta N et al. Determination of the active site of CD59 with synthetic peptides. Molecular Immunol 1995; 32:241-7.
3. White RV, Kaufman KM, Letson CS, Platteborze PL, Sodetz JM. Characterization of rabbit complement component C8. Functional evidence for the species-selective recognition of C8a by homologous restriction factor (CD59). J Immunol 1994;152: 2501-8.
4. Hüsler T, Locket DH, Kaufman KM, Sodetz JM, Sims PJ. Chimeras of human complement C9 reveal the site recognized by complement regulatory protein CD59. J Biol Chem 1995;270: 3483-6.
5. Phibric WM, Palfree RGE, Maher SE, Bridgett MM, Sirlim S, Bothwell ALM. The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility. Eur J Immunol 1990;20:87-92.
6. Petranka JG, Fleenor DE, Sykes K, Kaufman RE, Rosse WF. Structre of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 protein. Proc Natl Acad Sci USA 1992;89:7876-9.
7. Brooimans RA, van Wieringen PAM, van Es LA, Daha MR. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis. Eur J Immunol 1992;22: 3135-40.
8. Hatanaka M, Seya T, Yoden A, Fukamoto K, Semba T, Inai S. Analysis of C5b-8 binding sites in the C9 molecule using monoclonal antibodies: Participation of two separate epitopes of C9 in C5b-8 binding. Molec Immunol 1992;29:911-16.
9. Fodor WL, Williams BL, Matis LA et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogenic hyperacute organ rejection. Proc Natl Acad Sci USA 1994;91:11153-7.
10. McCurry KR, Kooyman DL, Alvarado CG et al. Human complement regukatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Medicine 1995;1:423-7.
11. Miyagawa S, Hirose H, Shirakura R et al. The mechanism of discordant xenograft rejection. Transplantation 1988;46:825-30.
12. Miyagawa S, Shirakura R, Iwata K et al. Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAF hybrid, on complement-mediated swine endotherial cell lysis. Transplantation 1994;58:834-40.
13. Rosengard AM, Cary NRB, Langford GA, Tucker AW, Wallwork J, White DJG. Tissue expression of human complement inhibitor, dacay-accelerating factor, in transgenic pigs. A potential approach for prevention xenograft rejection. Transplantation 1995;59:1325-33.
14. Takebe Y, Seiki M, Fujisawa J et al. The SRa promoter: an efficient and versatile mammalian cDNA expression system composed of the SV40 early promoter and the R-U5 segment of human T cell leukemia virus type 1 LTR. Mol Cell Biol 1988; 8:466-72.
15. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukariotic vector. Gene 1991;108:193-200.
16. Seya T, Hara T, Matsumoto M, Akedo H. Quantative analysis of membrane cofactor proteine(MCP) of complement: high expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. J.Immunol 1990;145:238 45.
17. Hara T, Matsumoto M, Fukumori Y et al. A monoclonal antibody against human decay-accelerating factor (DAF,CD55), D17, which lacks reactivity with semen-DAF. Immunology Letters 1993;37:145-52.
18. Takata Y, Moriyama T, Fukumori Y, Yoden A, Shima M, Inai S. A biotin-avidin sandwich ELISA for quantification of intact complement component C9. The sera from hereditary C9 deficient individuals completely lack C9. J Immunol Methods 1998;117: 107-13.
19. Miyagawa S, Shirakura R, Matsumiya G et al. Test for ability of decay-accelerating factor(DAF, CD55) and CD59 to Alleviate complement-mediated damage of xeno-erythrocytes. Scand J Immunol 1993;38:37-44.
20. Brooimans RA, Van der Ark AA, Tomita M, Van Es LA, Daha MR. CD59 expressed by human endothelial cells function as a protective molecule against complement-mediated lysis. Eur J Immunol 1992;22:791-7.
21. Meri S, Mattila P, Renkonen R. Regulation of CD59 expression on the human endothelial cell line EA.hy926. Eur J Immunol 1993;23:2511-16.
22. Kennedy SP, Rollins SA, Burton WV et al. Protection of porcaine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59. Transplantation 1994;57:1494-501.
23. Charreau B, Cassard A, Tesson L et al. Protection of rat endothelial cells from primate complement-mediated lysis by-expression of human CD59 and or decay-accelerating factor. Transplantation 1994;58:1222-9.
24. Hamilton KK, Ji Z, Rollins S, Stewart BH, Sims PJ. Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59. Blood 1990;76:2572-7.
25. Carmen W, Berg VD, Morgan BP. Complement-inhibiting activation of human CD59 and analogues from rat, sheep, and pig are not homologously restrited. J Immunol 1994;152:4095-101.
26. Inai S, Akagaki Y, Moriyama T et al. Inherted deficiencies of the late-acting complement components other than C9 found among healthy blood donors. Int Arc Aller Appl Immunol 1998;90: 274-9.